Title: Cervical Cancer in Ethiopia: Insights from Recent Studies
Introduction:
Cervical cancer is a significant public health issue worldwide, with developing countries bearing a disproportionate burden. In Ethiopia, cervical cancer has been identified as a leading cause of cancer-related mortality among women. To address this issue, several studies have been conducted to understand the incidence, predictors, risk factors, and screening utilization rates in the country. This article aims to provide a comprehensive overview of key studies conducted on cervical cancer in Ethiopia and highlight their findings.
Cervical Cancer Incidence and Mortality Estimates in 2018:
The study by Arbyn et al. (2020) analyzed global cervical cancer incidence and mortality estimates. While the study did not focus solely on Ethiopia, it provides valuable insights into the global burden of cervical cancer.
Cervical Cancer Predictors of Advanced Stage and Long Time to Diagnosis:
The study by Begoihn et al. (2019) explored the predictors of advanced stage and long time to diagnosis of cervical cancer in Ethiopia. The findings shed light on the challenges women face in accessing timely and effective care for cervical cancer.
Cervical Cancer Screening Utilization and Health Belief Model:
The study by Gemeda et al. (2020) investigated the prevalence and predictors of cervical cancer screening utilization among women aged 25 years and older in the Sidama area of southern Ethiopia, using the health belief model. The study highlights the factors influencing screening utilization and emphasizes the importance of promoting awareness and knowledge about cervical cancer screening.
Gender Disparity in the Epidemiological Trend of HIV/AIDS Infection and Treatment:
The study by Girum et al. (2018) examined the gender disparity in the epidemiological trend of HIV/AIDS infection and treatment in Ethiopia. While the study does not focus specifically on cervical cancer, it provides important context as HIV infection is known to be a significant risk factor for cervical cancer.
Cervical Cancer Outcomes among HIV-Infected and Uninfected Women:
The study by Ferreira et al. (2017) compared cervical cancer outcomes among HIV-infected and uninfected women treated at the Brazilian National Cancer Institute. Although the study was conducted in Brazil, its findings are relevant to understanding the impact of HIV infection on cervical cancer outcomes in Ethiopia as well.
Preventable Noncommunicable Disease: Cervical Cancer in Sub-Saharan Africa:
The study by Mboumba Bourassa et al. (2017) focused on cervical cancer in sub-Saharan Africa and emphasized the importance of prevention strategies for this preventable noncommunicable disease. The insights from this study are highly applicable to Ethiopia and highlight the need for effective prevention and early detection programs.
Trends in the Incidence of Cervical Cancer in Sub-Saharan Africa:
The study by Jedy-Agba et al. (2020) examined trends in the incidence of cervical cancer in sub-Saharan Africa. While the study does not specifically focus on Ethiopia, it provides important information about the changing patterns of cervical cancer in the region.
Visual Inspection Methods for Cervical Cancer Detection among HIV-Infected Women:
The study by Huchko et al. (2014) compared two visual inspection methods for cervical cancer detection among HIV-infected women in Kenya. Although the study was conducted in Kenya, its findings are relevant to understanding the efficacy of different screening methods in resource-limited settings, including Ethiopia.
Performing the OncoE6 Cervical Test with Self-Sampling:
The study by Krings et al. (2018) explored the feasibility of performing the OncoE6 cervical test with self-sampling methods. The findings suggest that self-sampling could be a valuable screening option in settings where access to healthcare facilities is limited, such as rural areas in Ethiopia.
Conclusion:
Cervical cancer continues to be a significant health challenge in Ethiopia. The studies discussed in this article have provided valuable insights into the incidence, risk factors, predictors, screening utilization, and outcomes of cervical cancer in the country. These findings emphasize the urgent need for comprehensive prevention and control programs, including increasing awareness, promoting screening utilization, improving access to healthcare services, and addressing the factors contributing to delayed diagnosis and advanced stage presentation. With the implementation of evidence-based strategies, it is possible to reduce the burden of cervical cancer in Ethiopia and improve women’s health outcomes.
—————————————————-
| Article | Link |
|---|---|
| UK Artful Impressions | Premiere Etsy Store |
| Sponsored Content | View |
| 90’s Rock Band Review | View |
| Ted Lasso’s MacBook Guide | View |
| Nature’s Secret to More Energy | View |
| Ancient Recipe for Weight Loss | View |
| MacBook Air i3 vs i5 | View |
| You Need a VPN in 2023 – Liberty Shield | View |
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Cervical cancer incidence and mortality estimates in 2018: a global analysis. The Lancet Global Health. 2020;8(2):e191–e203.
Academic google
Begoihn M, Mathewos A, Aynalem A, Wondemagegnehu T, Moelle U, Gizaw M, et al. Cervical cancer in Ethiopia: predictors of advanced stage and long time to diagnosis. Infectious agents cancer. 2019;14(1):1–7.
Academic google
Gemeda EY, Kare BB, Negera DG, Bona LG, Derese BD, Akale NB, et al. Prevalence and predictor of cervical cancer screening utilization among women aged 25 years and older in the Sidama area, southern Ethiopia, using the health belief model. Cancer control. 2020;27(1):1073274820954460.
Academic google
Girum T, Wasie A, Lentiro K, Muktar E, Shumbej T, Difer M, et al. Gender disparity in the epidemiological trend of HIV/AIDS infection and treatment in Ethiopia. Public Health Archives. 2018;76(1):1–10.
Academic google
Ferreira MP, Coghill AE, Chaves CB, Bergmann A, Thuler LC, Soares EA et al. Cervical cancer outcomes among HIV-infected and uninfected women treated at the Brazilian National Cancer Institute (2001-2013). AIDS (London, England). 2017;31(4):523.
Mboumba Bourassa RS, Prazuck T, Lethu T, Jenabian MA, Meye JF, Bélec L. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease. Anti-infective therapy Expert Rev. 2017;15(6):613–27.
Academic google
Jedy-Agba E, Joko WY, Liu B, Buziba NG, Borok M, Korir A, et al. Trends in the incidence of cervical cancer in sub-Saharan Africa. HJ Cancer. 2020;123(1):148–54.
Academic google
Huchko MJ, Sneden J, Leslie HH, Abdulrahim N, Maloba M, Bukusi E, et al. A comparison of two visual inspection methods for cervical cancer detection among HIV-infected women in Kenya. Bull World Health Organization. 2014;92:195–203.
Academic google
Krings A, Dückelmann AM, Moser L, Gollrad J, Wiegerinck M, Schweizer J, et al. Performing the OncoE6 cervical test with collection methods that allow self-sampling. BMC Women’s Health. 2018;18(1):1–7.
Academic google
IAfRo cancer. Latest world data on cancer. Press release. 2018(263).
Makuza JD, Nsanzimana S, Muhimpundu MA, Pace LE, Ntaganira J, Riedel DJ. Prevalence and risk factors of cervical cancer and precancerous lesions in Rwanda. Pan Afr Med J. 2015;22(1).
Taye BT, Mihret MS, Muche HA. Risk factors for precancerous lesions of the cervix: the role of sociodemographic, sexual behavior and body mass index of women in referral hospitals in the Amhara region; A case-control study. Plus one. 2021;16(3):e0249218.
Academic google
Durowade K, Osagbemi G, Salaudeen A, Musa O, Akande T, Babatunde O, et al. Prevalence and risk factors for cervical cancer among women in an urban community in Kwara State, North Central Nigeria. J prev med hig. 2012;53(4):213–9.
Academic google
Almiraw JA, Asres AW, Adella GA. Predictors of cervical precancerous lesions among women screened for cervical cancer in the city of Bahir Dar, Ethiopia: a case-control study. Cancer Manage Res. 2020:6331–9.
Gelibo T, Roets L, Getachew T, Bekele A. Coverage and factors associated with cervical cancer screening: results of a population-based WHO step study in Ethiopia. Treatment Adv Oncol Res. 2017;1(115):2.
Academic google
Okwi LA, Wandabwa J, Okoth A, Othieno E. Prevalence of cancerous and premalignant lesions of cervical cancer and its association with observed risk factors among women in regions of Uganda. 2017.
Getinet M, Gelaw B, Sisay A, Mahmoud EA, Assefa A. Prevalence and predictors of cervical epithelial cell abnormalities on Pap smear among HIV-positive and negative women attending a gynecologic examination at the cancer screening center of cervix at Debre Markos referral hospital, East Gojjam, North West. Ethiopia. BMC Clin Pathol. 2015;15(1):1–10.
Academic google
Shiferaw N, Brooks MI, Salvador-Dávila G, Lonsako S, Kassahun K, Ansel J et al. Knowledge and awareness about cervical cancer among HIV-infected women in Ethiopia. Obstetrics and Gynecology International. 2016;2016.
FMoH E. In: Address dpac, editor. National cancer control plan 2016-2020. Addis Ababa Directorate of Disease Prevention and Control; 2015.
W.H. organization. WHO guidelines for the detection and treatment of precancerous lesions for the prevention of cervical cancer. World Health Organization; 2013.
The Sokkary HHAH. Comparison between Pap smear and visual inspection with acetic acid in screening for premalignant cervical intraepithelial lesion and early subclinical cervical cancer. Int J Reprod Contraceptive Obstet Gynecol. 2017;6(1):54–60.
Academic google
Shiferaw N, Salvador-Davila G, Kassahun K, Brooks MI, Weldegebreal T, Tilahun Y, et al. The single-visit approach as a cervical cancer prevention strategy among HIV-positive women in Ethiopia: successes and lessons learned. Global health: science and practice. 2016;4(1):87–98.
Academic google
W.H. organization. WHO guidelines for the pharmacological and radiotherapeutic treatment of cancer pain in adults and adolescents. 2018.
Kassa RT. Risk factors associated with precancerous cervical lesions among women examined at Marie Stops Ethiopia, Adama City, Ethiopia 2017: a case-control study. BMC Resolution Notes. 2018;11(1):1–5.
Academic google
Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden around the world and in China: a secondary analysis of world cancer statistics 2020. Chin Med J. 2021;134(07):783–91.
Academic google
Take down SM. Cervical cancer trends in Ethiopia. Cervical cancer. 2015;1(1):1–4.
Academic google
Gessesse Z, Tadesse Z, Alemayehu M, Hiruye A, Getachew Y, Derbew M, et al. Determinants of visual inspection with acetic acid-positive lesions (VIA) among HIV-positive women at Mekelle Hospital, northern Ethiopia: a case-control study. EMJ. 2015;1:17–24.
Academic google
Bezabih M, Tessema F, Sengi H, Deribew A. Risk factors associated with invasive cervical carcinoma among women attending Jimma University Specialized Hospital, Southwestern Ethiopia: a case-control study. Ethiopia J health sciences. 2015;25(4):345–52.
Academic google
Teame H, Addissie A, Ayele W, Hirpa S, Gebremariam A, Gebreheat G, et al. Factors associated with precancerous lesions of the cervix among women undergoing cervical cancer screening in Addis Ababa, Ethiopia: a case-control study. Plus one. 2018;13(1):e0191506.
Academic google
Faktörleri OKR, Vaka-Kontrol H. Ovarian cancer risk factors: results of a hospital-based case-control study. Turkiye Klinikleri J Med Sci. 2010;30(1):79–87.
Academic google
Carneiro F. World Cancer Report 2014. Stewart BW and Savage CP Cancer by Organ Location: Stomach Cancer Lyon. France IARC. 2014;2(14):383–91.
Academic google
Aweke YH, Ayanto SY, Ersado TL. Knowledge, attitude, and practice for the prevention and control of cervical cancer among women of childbearing age in Hossana town, Hadiya zone, southern Ethiopia: a cross-sectional community study. Plus one. 2017;12(7):e0181415.
Academic google
Leece P, Kendall C, Touchie C, Pottie K, Angel JB, Jaffey J. Cervical cancer screening among HIV-positive women: a retrospective cohort study from a tertiary care HIV clinic. Can Fam Medical. 2010;56(12):e425–e31.
Academic google
Dessalegn Mekonnen B. Acceptance of cervical cancer screening and associated factors among HIV-positive women in Ethiopia: a systematic review and meta-analysis. Advances in Preventive Medicine. 2020;2020.
Beyene T, Akibu M, Bekele H, Seyoum W. Risk factors for precancerous cervical lesion among women screened for cervical cancer in southern Ethiopia: unmatched case-control study. Plus one. 2021;16(7):e0254663.
Academic google
Mekuria M, Edosa K, Endashaw M, Bala ET, Chaka EE, Deriba BS, et al. Cervical cancer prevalence and associated factors among women attending the cervical cancer screening center at Gahandi Memorial Hospital, Ethiopia. Cancer report. 2021;20:11769351211068431.
Academic google
Almiraw JA, Asres AW, Adella GA. Predictors of cervical precancerous lesions among women screened for cervical cancer in the city of Bahir Dar, Ethiopia: a case-control study. Cancer Manage Res. 2020;12:6331.
Academic google
Abebe M, Eshetie S, Tessema B. Prevalence of sexually transmitted infections among women with suspected cervical cancer at Gondar University Specialized Comprehensive Hospital, North-West Ethiopia. BMC infectious disease. 2021;21(1):1–7.
Academic google
Ephrem Dibisa K, Tamiru Dinka M, Mekonen Moti L, Fetensa G. Cervical precancerous lesion and associated factors among women from West Wollega, West Ethiopia, 2022. Cancer control. 2022;29:10732748221117900.
Academic google
SK SK, KZ KZ, PRECANCEROUS CERVICAL LESIONS AMONG HIV-INFECTED. WOMEN IN REFERRAL HOSPITALS IN THE AMHARA REGION, NORTHWEST ETHIOPIA.
Teklehaimanot DA, Derseh BT, Mekuria AD, Dadi AF. Sexually transmitted infections (STIs) increased the risk of precancerous lesions of the cervix among women in Ethiopia: unmatched case-control study. 2022.
Weldegebreal F, Worku T. Precancerous cervical lesion among HIV-positive women in sub-Saharan Africa: a systematic review and meta-analysis. Cancer control. 2019;26(1):1073274819845872.
Academic google
Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women are at increased risk of human papillomavirus infection, precancerous lesions, and cervical cancer. AIDS. 2018;32(6):795–808.
Academic google
https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-023-02580-0
—————————————————-